5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies

S Spadari, G Ciarrocchi, F Focher, A Verri, G Maga, F Arcamone, E Iafrate, S Manzini, A Garbesi and L Tondelli

Istituto di Genetica Biochimica ed Evoluzionistica, Consiglio Nazionale delle Ricerche, Pavia, Italy.

5-Iodo-2'-deoxy-L-uridine (L-IdU) and (E)-5-(2-bromovinyl)-2'-deoxy-L- uridine (L-BVdU) have been prepared and found to inhibit herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) with activities comparable to those of their analogs with the natural D-sugar configuration. The mechanism of inhibition is purely competitive for L-IdU (Ki = 0.24 microM) and mixed-type for L-BVdU (Ki = 0.13 microM). High performance liquid chromatographic analysis of the reaction products demonstrated that the viral enzyme phosphorylates both L-enantiomers to their corresponding monophosphates with efficiency comparable to that for D- enantiomers. Neither L-enantiomer inhibits the human cytosolic TK. In contrast to their D-enantiomers, L-IdU and L-BVdU have no effect on human thymidylate synthase, either in HeLa cells or in TK-deficient HeLa cells transformed with the HSV-1 TK gene. Both L-enantiomers (i) have no effect on HeLa cell growth, (ii) are 1000-fold less cytotoxic toward TK-deficient HeLa cells transformed with the HSV-1 TK gene than are their D-enantiomers, (iii) in contrast to their D-enantiomers, are fully resistant to hydrolysis by nucleoside phosphorylase, and, (iv) in spite of their much lower cytotoxicity, most probably due to the very low affinity of L-BVdU monophosphate and L-IdU monophosphate for thymidylate synthase, are only 1 or 2 orders of magnitude less potent than their D-enantiomers in inhibiting viral growth, with potency comparable to that of acyclovir.

Volume 47, Issue 6, pp. 1231-1238, 06/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				F. Focher, A. Lossani, A. Verri, S. Spadari, A. Maioli, J. J. Gambino, G. E. Wright, R. Eberle, D. H. Black, P. Medveczky, et al. Sensitivity of Monkey B Virus (Cercopithecine herpesvirus 1) to Antiviral Drugs: Role of Thymidine Kinase in Antiviral Activities of Substrate Analogs and Acyclonucleosides Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2028 - 2034. [Abstract] [Full Text] [PDF]

				M. T. Hess, H. Naegeli, and M. Capobianco Stereoselectivity of Human Nucleotide Excision Repair Promoted by Defective Hybridization J. Biol. Chem., October 23, 1998; 273(43): 27867 - 27872. [Abstract] [Full Text] [PDF]

				A. Verri, F. Focher, G. Priori, G. Gosselin, J.-L. Imbach, M. Capobianco, A. Garbesi, and S. Spadari Lack of Enantiospecificity of Human 2'-Deoxycytidine Kinase: Relevance for the Activation of beta -L-Deoxycytidine Analogs as Antineoplastic and Antiviral Agents Mol. Pharmacol., January 1, 1997; 51(1): 132 - 138. [Abstract] [Full Text]

				X.-Q. Wang, P. Sun, and A. S. Paller Inhibition of Integrin-linked Kinase/Protein Kinase B/Akt Signaling. MECHANISM FOR GANGLIOSIDE-INDUCED APOPTOSIS J. Biol. Chem., November 21, 2001; 276(48): 44504 - 44511. [Abstract] [Full Text] [PDF]